NCT06275178

Brief Summary

This study is a national multicenter retrospective study. Patients with unexplained pleural effusion who underwent thoracoscopic or video-assisted thoracoscopic biopsy for patients in recent 10 years were retrospectively collected from multiple centers to understand the proportion and final etiological composition of pleural effusion in China.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 23, 2024

Completed
26 days until next milestone

Study Start

First participant enrolled

March 20, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2024

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

9 months

First QC Date

February 17, 2024

Last Update Submit

February 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The proportion of fibrinous pleurisy in Chinese population

    The proportion of fibrinous pleurisy in Chinese population

    December 31, 2024

Interventions

The included particpants are the patients with unexplained pleural effusion who underwent thoracoscopic or video-assisted thoracoscopic biopsy.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with pleural effusion who underwent medical thoracoscopy were included in the study. Patients who could not obtain a final diagnosis were excluded from the study

You may qualify if:

  • Patients with unexplained pleural effusion who underwent thoracoscopic or video-assisted thoracoscopic biopsy

You may not qualify if:

  • Patients who cannot obtain a final diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pleural EffusionPleural Effusion, Malignant

Condition Hierarchy (Ancestors)

Pleural DiseasesRespiratory Tract DiseasesPleural NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasms

Central Study Contacts

Mingming Deng, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 17, 2024

First Posted

February 23, 2024

Study Start

March 20, 2024

Primary Completion

December 24, 2024

Study Completion

December 31, 2024

Last Updated

February 23, 2024

Record last verified: 2024-02